Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis

  • Authors:
    • Su‑Xia Guo
    • Zhen‑Yu Yang
    • Ru‑Xing Wang
    • Ying Yang
    • Hua‑Ming Cao
    • Tao Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The Affiliated People's Hospital of Nanjing Medical University in Wuxi and People's Hospital of Wuxi City, Jiangsu, Wuxi 214023, P.R. China
  • Pages: 539-544
    |
    Published online on: December 5, 2012
       https://doi.org/10.3892/etm.2012.852
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Studies have shown that a C1019T polymorphism of the gene encoding the gap junction protein connexin37 is associated with coronary artery disease (CAD). The aim of the present study was to explore the association between the C1019T polymorphism in the connexin37 gene and CAD patients with in‑stent restenosis (ISR). A total of 532 patients who had undergone coronary stenting and coronary angiography at least three months after the procedure were divided according to a clinical diagnosis standard into two groups which were ISR (n=67) and no in‑stent restenosis (NISR; n=465) groups. A further 501 healthy individuals were controls. The subjects were genotyped by DNA sequencing. The results demonstrated the following: i) connexin37 gene 1019 sites in the population were distributed by polymorphism into three genetic types (CC, TC and TT types). The distribution frequency of the healthy control, ISR and NISR groups conformed to the Hardy‑Weinberg genetic balance rule; ii) in comparison with the healthy controls, the frequency of the connexin37 C allele was higher in the CAD patients (57.05% vs. 41.32%; OR, 1.89; 95% CI, 1.58‑2.25; P<0.01). The frequency of the C carriers (CC+TC) was 65.47% in the healthy controls, vs. 79.32% in CAD patients (P<0.01). The CAD risk was significantly increased in the carriers of the C allele (CC+TC) compared with TT homozygotes (OR, 2.03; 95% CI, 1.53‑2.80; P<0.01). Stratified analysis demonstrated that a significant difference existed in the frequency of C carriers between the male CAD patients and healthy controls (79.63% vs. 72.45%; OR, 1.48; 95% CI, 1.06‑2.09, P=0.02), as well as in the female CAD patients (78.00% vs. 51.50%; OR, 3.34; 95% CI, 1.90‑5.86; P<0.01). In the female and male CAD patients, the frequency of the connexin37 C allele was higher than in the healthy controls (male: χ2=12.67, P<0.01; female: χ2=50.20, P<0.01); iii) compared with the NISR group, the frequencies of the connexin37 C allele and C carriers (CC+TC) were significantly higher in the ISR group (frequency of C allele: 72.39% vs. 54.84%; P<0.01; frequency of C carriers: 89.55% vs. 77.85%; P=0.03). Compared with TT homozygotes, the restenosis risk was significantly increased in the carriers of the C allele (CC+TC; OR, 2.44; 95% CI, 1.08‑5.50). Subsequent stratified analysis revealed that the frequency of the C allele was significantly higher in the male ISR group than in the male NISR group (78.57% vs. 52.66%; OR, 3.30; 95% CI, 2.05‑5.29; P<0.01). The restenosis risk was ~four‑fold higher in the C carriers (CC+TC) than in the TT homozygotes (OR, 3.74; 95% CI, 1.32‑10.64). However in the female population, there was no difference in the ISR risk between the carriers of the C allele (CC+TC) and the TT homozygotes (P=0.70). In summary, the C allele of the connexin37 gene is not only is associated with the susceptibility to CAD, but also associated with restenosis following coronary stenting in the population studied herein, particularly the male population.
View Figures

Figure 1

View References

1. 

Serruys PW, Kutryk MJ and Ong AT: Coronary-artery stents. N Engl J Med. 354:483–495. 2006. View Article : Google Scholar

2. 

Cheng G, Wang H, Chen M, et al: Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population. Exp Ther Med. 2:275–280. 2011.PubMed/NCBI

3. 

Yan KP, Guo Y, Xing Z, et al: Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats. Exp Ther Med. 3:314–318. 2012.PubMed/NCBI

4. 

Marfella R, Sasso FC, Siniscalchi M, et al: Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction. J Clin Endocrinol Metab. 97:2862–2871. 2012. View Article : Google Scholar

5. 

Kastrati A, Schömig A, Elezi S, et al: Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation. 97:2396–2401. 1998. View Article : Google Scholar : PubMed/NCBI

6. 

Weintraub WS, Kosinski AS, Brown CL III, et al: Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 21:6–14. 1993. View Article : Google Scholar : PubMed/NCBI

7. 

Saez JC, Berthoud VM, Branes MC, et al: Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 83:1359–1400. 2003. View Article : Google Scholar : PubMed/NCBI

8. 

Fang JS, Angelov SN, Simon AM and Burt JM: Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol. 301:H1872–H1881. 2011. View Article : Google Scholar : PubMed/NCBI

9. 

Kanady JD, Dellinger MT, Munger SJ, Witte MH and Simon AM: Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol. 354:253–266. 2011. View Article : Google Scholar : PubMed/NCBI

10. 

Morel S and Kwak BR: Roles of connexins in atherosclerosis and ischemia-reperfusion injury. Curr Pharm Biotechnol. 13:17–26. 2012. View Article : Google Scholar : PubMed/NCBI

11. 

Yeh HI, Chang HM, Lu WW, et al: Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem. 48:1377–1389. 2000. View Article : Google Scholar : PubMed/NCBI

12. 

Pfenniger A, Wong C, Sutter E, et al: Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells. J Mol Cell Cardiol. 53:299–309. 2012. View Article : Google Scholar : PubMed/NCBI

13. 

Fang JS, Angelov SN, Simon AM and Burt JM: Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recovery. J Vasc Res. 49:2–12. 2012. View Article : Google Scholar : PubMed/NCBI

14. 

Boerma M, Forsberg L, Van Zeij L, et al: A genetic polymorphismin connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med. 246:211–218. 1999. View Article : Google Scholar : PubMed/NCBI

15. 

Yeh HL, Chou Y, Liu HF, et al: Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol. 81:251–255. 2001. View Article : Google Scholar : PubMed/NCBI

16. 

Han YL, Xi SY, Zhang XL, et al: Association of C1019T polymorphism in the Connexin 37 gene and coronary artery disease in Chinese Han population. Zhonghua Yi Xue Za Zhi. 87:100–104. 2007.(In Chinese).

17. 

Wong CW, Christen T, Pfenniger A, et al: Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclorosis. 191:355–361. 2007. View Article : Google Scholar : PubMed/NCBI

18. 

Yamada Y, Izawa H, Ichiwara S, et al: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 347:1916–1923. 2002. View Article : Google Scholar : PubMed/NCBI

19. 

Listi F, Candore G, Lio D, et al: Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol. 102:269–271. 2005. View Article : Google Scholar : PubMed/NCBI

20. 

Chan JM, Rhee JW, Drum CL, et al: In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci U S A. 108:19347–19352. 2011. View Article : Google Scholar : PubMed/NCBI

21. 

Egan CG, Caporali F, Huqi AF, et al: Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics. Thromb Haemost. 101:1138–1146. 2009.PubMed/NCBI

22. 

Stiefel P, Moreno-Luna R, Vallejo-Vaz AJ, et al: Which parameter is better to define endothelial dysfunction in a test of postocclusive hyperemia measured by laser-Doppler flowmetry? Coron Artery Dis. 23:57–61. 2012. View Article : Google Scholar

23. 

Leu HB, Chung CM, Chuang SY, et al: Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke. Atherosclerosis. 214:101–106. 2011. View Article : Google Scholar : PubMed/NCBI

24. 

Puljung MC, Berthoud VM, Beyer EC and Hanck DA: Polyvalent cations constitute the voltage gating particle in human connexin37 hemichannels. J Gen Physiol. 124:587–603. 2004. View Article : Google Scholar : PubMed/NCBI

25. 

Cai WJ, Koltai S, Kocsis E, et al: Connexin37, not Cx40 and Cx43, is induced in vascular smooth muscle cells during coronary arteriogenesis. J Mol Cell Cardiol. 33:957–967. 2001. View Article : Google Scholar : PubMed/NCBI

26. 

Wong CW, Christen T, Roth I, et al: Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med. 12:950–954. 2006. View Article : Google Scholar : PubMed/NCBI

27. 

Collings A, Raitakari OT, Juonala M, et al: The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism - The Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med. 46:1102–1108. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guo SX, Yang ZY, Wang RX, Yang Y, Cao HM and Zhang T: Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis. Exp Ther Med 5: 539-544, 2013.
APA
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., & Zhang, T. (2013). Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis. Experimental and Therapeutic Medicine, 5, 539-544. https://doi.org/10.3892/etm.2012.852
MLA
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., Zhang, T."Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis". Experimental and Therapeutic Medicine 5.2 (2013): 539-544.
Chicago
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., Zhang, T."Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis". Experimental and Therapeutic Medicine 5, no. 2 (2013): 539-544. https://doi.org/10.3892/etm.2012.852
Copy and paste a formatted citation
x
Spandidos Publications style
Guo SX, Yang ZY, Wang RX, Yang Y, Cao HM and Zhang T: Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis. Exp Ther Med 5: 539-544, 2013.
APA
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., & Zhang, T. (2013). Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis. Experimental and Therapeutic Medicine, 5, 539-544. https://doi.org/10.3892/etm.2012.852
MLA
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., Zhang, T."Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis". Experimental and Therapeutic Medicine 5.2 (2013): 539-544.
Chicago
Guo, S., Yang, Z., Wang, R., Yang, Y., Cao, H., Zhang, T."Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in‑stent restenosis". Experimental and Therapeutic Medicine 5, no. 2 (2013): 539-544. https://doi.org/10.3892/etm.2012.852
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team